Guidance

Complete routine immunisation schedule from 1 September 2023

Updated 20 October 2023

For vaccine supply information for the routine immunisation schedule please visit ImmForm and check Vaccine Update for all other vaccine supply information.

Complete routine immunisation schedule from 1 September 2023

When	Diseases protected against	Vaccine given	Trade name	Usual site [footnote 1]
8 weeks old	Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B	DTaP/IPV/Hib/HepB	Infanrix hexa or Vaxelis	Thigh
	Meningococcal group B (MenB)	MenB	Bexsero	Left thigh
	Rotavirus gastroenteritis	Rotavirus [footnote 2]	Rotarix [footnote 2]	By mouth
12 weeks old	Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B	DTaP/IPV/Hib/HepB	Infanrix hexa or Vaxelis	Thigh
	Pneumococcal (13 serotypes)	Pneumococcal conjugate vaccine (PCV)	Prevenar 13	Thigh
	Rotavirus	Rotavirus [footnote 2]	Rotarix [footnote 2]	By mouth
16 weeks old	Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B	DTaP/IPV/Hib/HepB	Infanrix hexa or Vaxelis	Thigh
	MenB	MenB	Bexsero	Left thigh
1 years old (on or after the child’s first birthday)	Hib and Meningococcal group C (MenC)	Hib/MenC	Menitorix	Upper arm or thigh
	Pneumococcal	PCV booster	Prevenar 13	Upper arm or thigh
	Measles, mumps and rubella (German measles)	MMR	MMRvaxPro [footnote 3] or Priorix	Upper arm or thigh
	MenB	MenB booster	Bexsero	Left thigh
Eligible paediatric age group [footnote 4]	Influenza (each year from September)	Live attenuated influenza vaccine LAIV [footnote 3], [footnote 5]	Fluenz Tetra [footnote 3], [footnote 5]	Both nostrils
3 years 4 months old or soon after	Diphtheria, tetanus, pertussis and polio	dTaP/IPV	Boostrix-IPV	Upper arm
	Measles, mumps and rubella	MMR (check first dose given)	MMRvaxPro [footnote 3] or Priorix	Upper arm
Boys and girls aged 12 to 13 years	Cancers and genital warts caused by specific human papillomavirus (HPV) types	HPV [footnote 6]	Gardasil 9	Upper arm
14 years old (school Year 9)	Tetanus, diphtheria and polio	Td/IPV (check MMR status)	Revaxis	Upper arm
	Meningococcal groups A, C, W and Y	MenACWY	Nimenrix	Upper arm
65 years old	Pneumococcal (23 serotypes)	Pneumococcal polysaccharide vaccine (PPV23)	Pneumovax 23	Upper arm
65 years of age and older	Influenza (each year from September)	Inactivated influenza vaccine	Multiple	Upper arm
65 from September 2023 [footnote 7]	Shingles	Shingles vaccine	Shingrix	Upper arm
70 to 79 years of age (plus eligible age groups and severely immunosuppressed) [footnote 7]	Shingles	Shingles vaccine	Zostavax [footnote 3], [footnote 7] (or Shingrix if Zostavax contraindicated)	Upper arm

Selective immunisation programmes

Target group	Age and schedule	Disease	Vaccines required
Babies born to hepatitis B infected mothers	At birth, 4 weeks and 12 months old [footnote 8], [footnote 9]	Hepatitis B	Hepatitis B (Engerix B/HBvaxPRO)
Infants in areas of the country with tuberculosis (TB) incidence >= 40/100,000	Around 28 days old [footnote 10]	Tuberculosis	BCG
Infants with a parent or grandparent born in a high incidence country [footnote 11]	Around 28 days old [footnote 10]	Tuberculosis	BCG
Children in a clinical risk group	From 6 months to 17 years of age	Influenza	LAIV or inactivated flu vaccine if contraindicated to LAIV or under 2 years of age
Pregnant women	At any stage of pregnancy during flu season	Influenza	Inactivated flu vaccine
	From 16 weeks gestation [footnote 12]	Pertussis	dTaP/IPV (Boostrix-IPV)

Additional vaccines for individuals with underlying medical conditions

Medical condition	Diseases protected against	Vaccines required [footnote 13]
Asplenia or splenic dysfunction (including due to sickle cell and coeliac disease)	Meningococcal groups A, B, C, W and Y	MenACWY MenB
	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine
Cochlear implants	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, and heart failure)	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine
Chronic neurological conditions (such as Parkinson’s or motor neurone disease, or learning disability)	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine
Diabetes	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine
Chronic kidney disease (CKD) (including haemodialysis)	Pneumococcal (stage 4 and 5 CKD)	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza (stage 3, 4 and 5 CKD)	Annual flu vaccine
	Hepatitis B (stage 4 and 5 CKD)	Hepatitis B
Chronic liver conditions	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine
	Hepatitis A	Hepatitis A
	Hepatitis B	Hepatitis B
Haemophilia	Hepatitis A	Hepatitis A
	Hepatitis B	Hepatitis B
Immunosuppression due to disease or treatment [footnote 15]	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14], [footnote 16] PPV23 (from 2 years of age)
	Shingles vaccine	Shingrix – over 50 years of age [footnote 7]
	Influenza	Annual flu vaccine
Complement disorders (including those receiving complement inhibitor therapy)	Meningococcal groups A, B, C, W and Y	MenACWY MenB
	Pneumococcal	PCV13 (up to 10 years of age) [footnote 14] PPV23 (from 2 years of age)
	Influenza	Annual flu vaccine

1. Intramuscular injection into deltoid muscle in upper arm or anterolateral aspect of the thigh. ↩

2. Rotavirus vaccine should only be given after checking for a severe combined immunodeficiency (SCID) screening result. ↩ ↩² ↩³ ↩⁴

3. Contains porcine gelatine. ↩ ↩² ↩³ ↩⁴ ↩⁵

4. See annual flu letter ↩

5. If LAIV (live attenuated influenza vaccine) is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book chapter 19 for details). ↩ ↩²

6. See Green Book HPV chapter 18a for details on immunising immunocompromised young people who will need 3 doses. ↩

7. See Green Book shingles chapter 28a for details on eligible age groups including severely immunosuppressed individuals from age 50. ↩ ↩² ↩³ ↩⁴

8. Take blood for HBsAg at 12 months to exclude infection. ↩

9. In addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks. ↩

10. Check SCID screening outcome before giving BCG. ↩ ↩²

11. Where the annual incidence of TB is >= 40/100,000 – see tuberculosis by country: rates per 100,000 people ↩

12. Ideally before 32 weeks gestation but may still be given after 32 weeks. ↩

13. Check relevant chapter of the Green Book for specific schedule ↩

14. If aged 2 years to under 10 years of age and unimmunised or partially immunised against pneumococcal infection, give one PCV13 dose. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹

15. Consider annual influenza vaccination for household members and those who care for people with these conditions. ↩

16. To any age in severely immunocompromised. ↩